Esteban Abella

Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498 [see comments]

Yaddanapudi Ravindranath, Esteban Abella, J. Krischer et al. · Blood · 1992 · 257 citations · Full text

Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma

V. Ratanatharathorn, Joseph P. Uberti, Chatchada Karanes et al. · Blood · 1994 · 226 citations · Full text

Assessment of Optimal Size and Composition of the U.S. National Registry of Hematopoietic Stem Cell Donors

Craig Kollman, Esteban Abella, Robert L. Baitty et al. · Transplantation · 2004 · 112 citations

A case report of a patient with microcephaly, facial dysmorphism, mitomycin-c-sensitive lymphocytes, and susceptibility to lymphoma

Sameer Bakhshi, Hans Joenje, Detlev Schindler et al. · Cancer Genetics and Cytogenetics · 2006 · 73 citations

FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis.

Arlene O. Siefker‐Radtke, Graeme Currie, Esteban Abella et al. · Journal of Clinical Oncology · 2019 · 64 citations

Immunology, Adjuvant Chemotherapy, Muc Pts +20